Abstract
Hemophagocytic lymphohistiocytosis (HLH) is characterized by uncontrolled activation of T cells and macrophages with overproduction of cytokines. Familial HLH type2 (FHL2) is the most common form of primary HLH and is caused by mutations in PRF1. We have recently described a significant increase in the subpopulation of CD8 + T cells with clonal expansion and CD5 down-regulation in Epstein-Barr virus associated-HLH, which represented a valuable tool for its diagnosis. However, this unusual phenotype of CD8 + T cells has not been investigated fully in patients with FHL2. We performed immunophenotypic analysis of peripheral blood and measured serum proinflammatory cytokines in 5 patients with FHL2. All patients showed significantly increased subpopulations of activated CD8 + T cells with down-regulation of CD5, which were negligible among normal controls. Analysis of T-cell receptor Vβ repertoire suggested the reactive and oligoclonal expansion of these cells. The proportion of the subset declined after successful treatment concomitant with reduction in the serum levels of cytokines in all patients except one who continued to have a high proportion of the subset and died. These findings suggest that down-regulation of CD5 on activated CD8 + T cells may serve as a useful marker of dysregulated T cell activation and proliferation in FHL2.
Introduction
Hemophagocytic lymphohistiocytosis (HLH) is a potentially fatal disease that is characterized by marked systemic inflammation and unregulated activation of macrophages and T cells [1, 2] . Patients with HLH may present with fever, cytopenia, hepatosplenomegaly, liver dysfunction, coagulation abnormalities, and hemophagocytosis [1, 2] . HLH is comprised of primary and secondary forms. Primary HLH includes familial HLH (FHL), which is caused by genetic defects related to granule-dependent cytotoxicity, and immunodeficiencies, such as X-linked lymphoproliferative syndrome. 
Materials and Methods

Patients
We studied 5 patients with FHL2 from 5 families, all of whom were born to nonconsanguineous Japanese parents. [12] , and died at 12 days of age. Patients P1, P3, P4 and P5 underwent stem cell transplantation at the ages of 5 mo, 2 yr, 5 mo and 5 mo, respectively [13] .
Patients P1and P3 are alive with no evidence of disease, but patient P4 died of acute graft-versus-host disease 5 months later. In patient P5, the transplantation was performed recently. We also investigated 10 cases of EBV-HLH and 13 cases of infectious mononucleosis (IM) as disease controls [5, 14] . All patients with EBV-HLH showed typical clinical features of HLH and exhibited high viral copy numbers. It was noted that 
Flow cytometry
For the analysis of perforin expression, peripheral blood mononuclear cells For the analysis of CD5 expression, whole blood was stained with fluorescein isothiocyanate-conjugated anti-CD5, PE-conjugated anti-human leukocyte antigen (HLA)-DR (both from BD), and R-PE-Cy5-conjugated anti-CD4 or anti-CD8 (Dako, Glostrup, Denmark) mAbs. CD5 expression on CD8 + T cells was considered negative if it was similar to levels of the NK cells and most of the B cells that do not express CD5 [5] .
Analysis of differences among the data groups was performed using Student's unpaired ttest. P-values less than 0.05 were considered significant. Flow cytometric analysis of the TCR Vβ repertoire was performed as previously described [15] . 8
Cytokine determination
Serum or plasma concentrations of cytokines were determined using the following enzyme-linked immunosorbent assay kits: interferon-γ and interleukin-6 (R&D systems, Minneapolis, MN); and neopterin (IBL, Hamburg, Germany) [14] .
Mutation analysis
DNA was extracted from blood samples using standard methods. The PRF1 gene was amplified from genomic DNA using specific primers [16] . Sequencing was performed on purified polymerase chain reaction products using the ABI Prism BigDye
Terminator Cycle sequencing kit on an ABI 3130 automated sequencer (Applied Biosystems, Foster, CA).
Cell cultures
To stimulate T cells, PBMCs were incubated for 72 h with 5 µg/mL phytohemagglutinin, with 1 µg/mL anti-CD3 (OKT3) plus 5 µg/mL anti-CD28 mAb, or with 20 ng/mL phorbol myristate acetate plus 250 ng/mL ionomycin in RPMI 1640 medium containing 10% fetal calf serum and antibiotics [17] .
Results
Perforin expression and PRF1 mutations
We first analyzed perforin expression by flow cytometry. As shown in Fig. 1 , perforin was not detectable in NK cells from patients P1, P2, P4 or P5. NK cells from patient P3 showed residual expression of the mutated perforin, which might be associated with the later age of onset, compared with the other patients. Table 2 presents the sequencing data for each patient. Patient P1 was a compound heterozygote bearing
Leu364fs and Tyr521Cys mutations in PRF1. The effect of the novel missense mutation
Tyr521Cys was evaluated using a web-based analysis tool, and was found to be deleterious on the basis of the SFIT program [18] . Two distinct frameshift mutations,
Pro333fs and Leu364fs, were demonstrated in patient P2. The former is a novel deletion mutation. The 1090_1091delCT (Leu364fs) mutation which was found in patients P1, P2, P4 and P5 has been repeatedly reported in Japanese patients with FHL2 [3] . All patients had at least one nonsense or frameshift mutation.
Increased subpopulation of activated CD8 + T cells with down-regulation of CD5
Immunophenotypic analysis of the lymphocytes demonstrated an increased percentage of CD8 + T cells expressing the activation marker HLA-DR in the acute phase of the disease (Table1, Fig. 2A ). Compared with CD8 + T cells, CD4 + T cells were less activated, except for patient P3 who had primary EBV infection. More importantly, the activated CD8 + T cells exhibited down-regulation of CD5, which was normally expressed on both CD4 + and CD8 + T cells from normal individuals ( Fig. 2A, 2B and died at 12 days of age. CD107 cytotoxicity assay was not performed in our patients.
CD5 expression on normal T cells after in vitro stimulation
To assess whether down-regulation of CD5 was induced on normal T cells after simulation, PBMCs from 3 normal individuals were cultured for 72 hours with phytohemagglutinin, anti-CD3 plus anti-CD28 mAbs, or phorbol myristate acetate plus ionomycin. Although normal CD8 + T cells expressed activation marker HLA-DR after any of the stimulation, CD5 was not down-regulated (Fig. 3) . We were not able to analyze expression of CD5 after in vitro stimulation using PBMCs from patients with FHL2 because no appropriate samples were available, except for from patient P4. No down-regulation of CD5 was observed on the stimulated CD8 + T cells from patient P4
(data not shown).
TCR Vβ repertoire of CD8 + T cells
We have previously demonstrated that activated and EBV-infected CD8 + T cells with down-regulation of CD5 proliferated clonally in patients with EBV-HLH [5] . To assess clonality of the CD8 + T cells from patients with FHL2, we investigated the diversity of the TCR Vβ repertoire in CD8 + T cells by flow cytometry (Fig. 4A) .
Although a massive expansion of a specific TCR Vβ has often been demonstrated for infection, acute herpes virus infections and peripheral T-cell neoplasma [19] [20] [21] [22] . In addition, a 17-day-old patient with FHL2 has been reported to exhibit uncontrolled proliferation of CD5 -CD8 + T cells that showed massive infiltration into the liver [11] . We therefore investigated whether this unusual subset of CD5 -CD8 + T cells was generally present in FHL2, which represents most common form of FHL.
In the present study, we demonstrated a significant increase in the subpopulation a rapidly fatal course [11] , it is necessary to identify a parameter that can predict severe cases of HLH, for which the timely initiation of life-saving therapy would be required.
Further investigations are underway to determine whether down-regulation of CD5 on activated CD8 + T cells could distinguish severe cases of HLH from other inflammatory conditions, including mild cases of HLH.
14 In summary, our studies demonstrate the increased subpopulation of activated CD8 + T cells with down-regulation of CD5 in the acute phase of FHL2, and point to an additional aspect of the immune dysregulation in this disease. 
